Ambulance injection could change heart attack care
Disease control
Ongoing
This study tests a single injection of zalunfiban given in the ambulance to people having a severe type of heart attack (STEMI). The goal is to see if the drug improves blood flow and reduces complications like death, stroke, or heart failure within 30 days. About 2,463 participa…
Phase: PHASE3 • Sponsor: CeleCor Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC